Burns 1999.
Methods | Parallel design Analysis: ITT: 2 withdrawn and 1 death (treatment), 1 death (placebo), last value carried forward |
|
Participants | Diagnosis: stroke. Months from stroke: median (range) 10.5 months (1 ± 156) in sertraline group and 5.5 months (1.5 ± 48) in the control group Treatment: 14 people Control: 14 people Exclusion criteria: less than 1 month since stroke, depression or dementia using the DSM III‐R criteria |
|
Interventions | Treatment: sertraline 50 mg daily Control: matched placebo Duration: treatment continued for 8 weeks Duration of follow‐up: 2 weeks off treatment. All scores became non‐significant (though data not reported so could not be used in the analysis) |
|
Outcomes | Able to use:
Method of collecting AEs was not stated Unable to use: MADRS, BI, MMSE (data not presented) |
|
Funding source | Funded by an unrestricted personal grant from Pfizer, the manufacturers of sertraline | |
Notes | Dates of study not stated, conflicts of interest not stated | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Blocks of 4 using list produced by medical statistics department |
Allocation concealment (selection bias) | Unclear risk | Not stated |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Matched placebo |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Run‐out was single‐blind, treatment was double‐blind, but unclear whether outcome assessors were blind |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Analysis: ITT, LOCF |
Selective reporting (reporting bias) | Low risk | Trial details published on www.strokecentre.org/trials, although unable to use data from MADRS Given that the main aim was to explore effect on emotionalism, this is unlikely to have biased results |
Other bias | Unclear risk | Placebo group younger, uncertain influence on bias Statistical analysis was carried out independently by the Applied Statistics Research Unit in Canterbury |